Literature DB >> 19012364

The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis.

Sharmayne R E Brady1, Barbora de Courten, Christopher M Reid, Flavia M Cicuttini, Maximilian P J de Courten, Danny Liew.   

Abstract

OBJECTIVE: People with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease (CVD) compared with the general population. We investigated the relative contribution of traditional cardiovascular risk factors to this elevated risk.
METHODS: Fifty RA subjects and 150 age and sex matched controls attended a cardiovascular risk assessment clinic betweenMarch and July 2006. Traditional cardiovascular risk factors and the absolute risks of CVD (calculated from application of a Framingham risk equation) were compared between the 2 groups.
RESULTS: Compared with the controls, RA subjects were more likely to smoke (p<0.001), be physically inactive (p=0.006), and have higher mean measurements of body mass index (p=0.040) and waist circumference (p=0.049). No significant differences were found in mean levels of plasma lipid or glucose, or in the prevalences of diabetes and hypertension. Overall, the mean absolute risk of CVD was higher in the RA group, even after excluding smokers (p=0.036).
CONCLUSION: Smoking and physical inactivity are important risk factors in the management of cardiovascular risk among patients with RA. Subjects with RA seem to have higher absolute risks of CVD compared with controls, even independently of smoking. This highlights the importance of treating all modifiable risk factors in those with RA although, individually, few may be conspicuous.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19012364     DOI: 10.3899/jrheum.080404

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.

Authors:  Anne Grete Semb; Eirik Ikdahl; Grunde Wibetoe; Cynthia Crowson; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2020-06-03       Impact factor: 20.543

Review 2.  Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.

Authors:  Katherine P Liao; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2012-09-16       Impact factor: 7.580

Review 3.  Cardiac involvement in juvenile idiopathic arthritis.

Authors:  Bulent Koca; Sezgin Sahin; Amra Adrovic; Kenan Barut; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2016-07-14       Impact factor: 2.631

Review 4.  [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis].

Authors:  S Kleinert; K Krueger
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

5.  Improving physical activity in arthritis clinical trial (IMPAACT): study design, rationale, recruitment, and baseline data.

Authors:  Rowland W Chang; Pamela A Semanik; Jungwha Lee; Joseph Feinglass; Linda Ehrlich-Jones; Dorothy D Dunlop
Journal:  Contemp Clin Trials       Date:  2014-08-23       Impact factor: 2.226

6.  Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study.

Authors:  J H Anderson; K R Anderson; H A Aulie; C S Crowson; T G Mason; S P Ardoin; A M Reed; B Flatø
Journal:  Scand J Rheumatol       Date:  2016-02-08       Impact factor: 3.641

7.  Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients.

Authors:  Gianluigi Mazzoccoli; Incoronata Notarsanto; Gennaro Davide de Pinto; Mariangela Pia Dagostino; Angelo De Cata; Giuseppe D'Alessandro; Roberto Tarquini; Gianluigi Vendemiale
Journal:  Intern Emerg Med       Date:  2010-09-16       Impact factor: 3.397

8.  Body composition of rheumatoid arthritis patients in the City of Cape Town, South Africa.

Authors:  L A Lombard; L M du Plessis; J Visser
Journal:  Clin Rheumatol       Date:  2013-11-07       Impact factor: 2.980

Review 9.  Novel mechanisms of action of the biologicals in rheumatic diseases.

Authors:  Cecilia Beatrice Chighizola; Ennio Giulio Favalli; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 10.  Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.

Authors:  Medha Barbhaiya; Daniel H Solomon
Journal:  Curr Opin Rheumatol       Date:  2013-05       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.